Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Corbus Pharmaceuticals Hldgs (CRBP)

106 + Investors. Track Smart Money conviction in CRBP. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +7
Streak
3Q ▲
Buyers last Q
58%

Smart Money Signals — CRBP

Based on 106 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added CRBP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
106 hedge funds hold CRBP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +26% more funds vs a year ago

fund count last 6Q
+22 new funds entered over the past year (+26% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 4 quarters from the low — a sharp move.
🟡

Slight buying edge — 58% buying

57 buying41 selling
Last quarter: 57 funds bought or added vs 41 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~23 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 13 → 21 → 27 → 23. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 37% long-term, 29% new

■ 37% conviction (2yr+) ■ 34% medium ■ 29% new
Of the 106 current holders: 39 (37%) held >2 years, 36 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📈

Growing discovery — still being found

15 → 13 → 21 → 27 → 23 new funds/Q
New funds entering each quarter: 13 → 21 → 27 → 23. A growing number of institutions are discovering CRBP each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 51% of holders stayed 2+ years

■ 51% veterans ■ 20% 1-2yr ■ 29% new
Of 114 current holders: 58 (51%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 17% AUM from top-100

17% from top-100 AUM funds
25 of 106 holders rank in the top 100 by AUM, but together hold only 17% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CRBP

In 2026 Q1, 57 hedge funds were net buyers of CRBP (23 opened a new position, 34 added to an existing one), while 41 reduced or exited (25 trimmed, 16 sold completely) — a 58% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. Net fund flow last quarter: +7 funds (more new holders than closures). Total institutional holders: 106.

Hedge Fund Ownership: CRBP

How many hedge funds hold CRBP — quarterly history vs. share price
Quarterly hedge fund ownership of CRBP vs. share price

Market Analysis: CRBP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CRBP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Corbus Pharmaceuticals Hldgs (CRBP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CRBP has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
CRBP
-12.8%
XLV
+4.9%

CRBP outperformed XLV by -17.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
CRBP
-25.7%
XLV
+6.0%

Since the filing became public, CRBP outperformed XLV by -31.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 0 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
0.7
/ 10
conviction
Hedge Fund Positioning: CRBP
106 + Investors

Track Smart Money conviction in CRBP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 106 99 7.07%
13F Shares 13M 13M 0.67%
Total Value $123M $107M 15.23%
New Positions 23 27 -4
Increased Positions 33 25 +8
Closed Positions 16 12 +4
Reduced Positions 22 25 -3
Total Calls 6 2 200.0%
Total Puts 2 0 100%
PUT/CALL Ratio 0.33 0.0 Bullish

Statistics: CRBP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

106 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CRBP. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CRBP holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Stonepine Capital Management, LLC 1.44% 383,462 $3.6M
2 Exome Asset Management LLC 1.14% 234,136 $2.2M
3 Cormorant Asset Management, LP 1.11% 2,344,971 $22.0M
4 Prosight Management, LP 1.07% 697,108 $6.5M
5 Diadema Partners LP 0.70% 439,957 $4.1M
6 Verdad Advisers, LP 0.53% 50,252 $472K
7 Rangeley Capital, LLC 0.41% 44,840 $421K
8 Persistent Asset Partners Ltd 0.39% 111,226 $1.0M
9 Orbimed Advisors LLC 0.32% 1,737,287 $16.3M
10 Seven Fleet Capital Management LP 0.26% 85,687 $805K
11 Diadema Partners LP 0.18% 115,300 $1.1M
12 ADAR1 Capital Management, LLC 0.18% 331,781 $3.1M
13 Velan Capital Investment Management LP 0.15% 26,000 $244K
14 Armistice Capital, LLC 0.06% 364,000 $3.4M
15 683 Capital Management, LLC 0.04% 85,543 $803K
16 Prelude Capital Management, LLC 0.04% 50,826 $477K
17 Aberdeen Group plc 0.02% 1,321,750 $12.4M
18 ADAR1 Capital Management, LLC 0.02% 35,000 $329K
19 Pale Fire Capital SE 0.02% 21,350 $200K
20 AlphaQuest LLC 0.01% 22,906 $186K
21 Laurion Capital Management LP 0.01% 19,600 $184K
22 XTX Topco Ltd 0.01% 38,023 $357K
23 Cantor Fitzgerald, L. P. 0.01% 40,098 $377K
24 Renaissance Technologies LLC 0.01% 346,998 $3.3M
25 Jump Financial, LLC 0.00% 30,600 $287K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Corbus Pharmaceuticals Hldgs (CRBP)

What does the Smart Money Trend signal show for CRBP?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added CRBP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CRBP?

Slight buying edge — 58% buying: Last quarter: 57 funds bought or added vs 41 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CRBP holders?

Smaller funds dominant — 17% AUM from top-100: 25 of 106 holders rank in the top 100 by AUM, but together hold only 17% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CRBP?

Mixed — 37% long-term, 29% new: Of the 106 current holders: 39 (37%) held >2 years, 36 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Corbus Pharmaceuticals Hldgs (CRBP) following the 2026 Q1 hedge fund 13F filings?

As of today, CRBP has moved -25.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -31.7%. Since the quarter end (March 31, 2026), CRBP has gained -12.8% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →